Literature DB >> 11294509

Limited sampling strategies for estimating cyclosporin area under the concentration-time curve: review of current algorithms.

O J David1, A Johnston.   

Abstract

Cyclosporin, the drug of first choice in transplantation surgery, is characterized by a low therapeutic index and variable absorption, so close monitoring of the drug is required to optimize the dosing. Predose blood cyclosporin levels are measured routinely for therapeutic monitoring, but this approach is not optimal because the area under the concentration-time curve (AUC) correlates better with clinical events. However, conventional methods of measuring AUC require many blood samples, which is not viable in a routine clinical setting. AUC monitoring can be simplified for use in a clinical setting by using a limited sampling strategy (LSS) that allows AUC to be estimated using a small number of blood samples collected at specific times. This article reviews the current literature on estimating cyclosporin AUC using LSS. Thirty-eight papers suggesting the use of specific time points were found. LSS has been developed for different transplant types, with different dosing regimens, and with different assays. Most authors suggested either two- or three-sample equations. Results from authors who validated their models suggest that equations defined on one transplant type may be applicable to other transplant types, to both adults and children, and to early or late after transplantation. Moreover, it seems that there is flexibility in the choice of equations available to clinicians. The number of samples to collect for accurate estimations is a matter of debate, but a wise choice can minimize the number. The choice of the optimal LSS and validation are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11294509     DOI: 10.1097/00007691-200104000-00003

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  20 in total

Review 1.  Clinical mycophenolic acid monitoring in liver transplant recipients.

Authors:  Hao Chen; Bing Chen
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.

Authors:  Hélène Bourgoin; Gilles Paintaud; Matthias Büchler; Yvon Lebranchu; Elisabeth Autret-Leca; France Mentré; Chantal Le Guellec
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

Review 3.  Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I.

Authors:  Caroline Monchaud; Pierre Marquet
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

4.  Evaluation of limited sampling models for prediction of oral midazolam AUC for CYP3A phenotyping and drug interaction studies.

Authors:  Silke C Mueller; Bernd Drewelow
Journal:  Eur J Clin Pharmacol       Date:  2012-11-07       Impact factor: 2.953

5.  Limited sampling strategy for determining metformin area under the plasma concentration-time curve.

Authors:  Ana Beatriz Santoro; Tore Bjerregaard Stage; Claudio José Struchiner; Mette Marie Hougaard Christensen; Kim Brosen; Guilherme Suarez-Kurtz
Journal:  Br J Clin Pharmacol       Date:  2016-07-24       Impact factor: 4.335

6.  Population pharmacokinetic study of cyclosporine in Chinese renal transplant recipients.

Authors:  Bing Chen; WeiXia Zhang; ZhiDong Gu; Juan Li; YuXin Zhang; WeiMin Cai
Journal:  Eur J Clin Pharmacol       Date:  2010-12-16       Impact factor: 2.953

7.  Evaluation of limited sampling strategies for tacrolimus.

Authors:  Robert A M Op den Buijsch; Afke van de Plas; Leo M L Stolk; Maarten H L Christiaans; Johannes P van Hooff; Nas A Undre; Marja P van Dieijen-Visser; Otto Bekers
Journal:  Eur J Clin Pharmacol       Date:  2007-08-22       Impact factor: 2.953

8.  Cyclosporin therapeutic drug monitoring--an established service revisited.

Authors:  Raymond G Morris
Journal:  Clin Biochem Rev       Date:  2003-05

9.  A time-to-event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A.

Authors:  Anne-Kristina Frobel; Mats O Karlsson; Janne T Backman; Kalle Hoppu; Erik Qvist; Paula Seikku; Hannu Jalanko; Christer Holmberg; Ron J Keizer; Samuel Fanta; Siv Jönsson
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

10.  Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.

Authors:  C Monchaud; A Rousseau; F Leger; O J David; J Debord; T Dantoine; P Marquet
Journal:  Eur J Clin Pharmacol       Date:  2003-03-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.